Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction

Murtha LA. et al, (2023), Nature: Scientific Reports

Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction

Hardy S. et al, (2023), JACC: Basic to Translational Science

Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies.

Mabotuwana NS. et al, (2022), Stem Cell Rev Rep, 18, 2606 - 2628

Small molecule STING inhibition improves myocardial infarction remodeling.

Rech L. et al, (2022), Life Sci, 291

STING inhibition in myocardial remodelling following myocardial infarction

Rech L. et al, (2021), European Heart Journal, 42

The Role of Pathological Aging in Cardiac and Pulmonary Fibrosis.

Murtha LA. et al, (2019), Aging Dis, 10, 419 - 428

Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction.

Hardy SA. et al, (2019), PLoS One, 14

Include forthcoming?